| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:CID-7309015
CAS:1164457-99-1
Package:25mg/RMB 10600;100mg/RMB 17500;50mg/RMB 13800
|
| Company Name: |
Specs
|
| Tel: |
+31 15 251 8111 |
| Email: |
info@specs.net |
| Products Intro: |
|
8-[3-(3,4-dimethoxyphenyl)acryloyl]-7-hydroxy-4-methyl-2H-chromen-2-one manufacturers
- CID-7309015
-
- $1520.00 / 25mg
-
2025-08-21
- CAS:1164457-99-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 8-[3-(3,4-dimethoxyphenyl)acryloyl]-7-hydroxy-4-methyl-2H-chromen-2-one Basic information |
| | 8-[3-(3,4-dimethoxyphenyl)acryloyl]-7-hydroxy-4-methyl-2H-chromen-2-one Chemical Properties |
| | 8-[3-(3,4-dimethoxyphenyl)acryloyl]-7-hydroxy-4-methyl-2H-chromen-2-one Usage And Synthesis |
| Description | CID-7309015 is an inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1), delayed death of the malarial parasite plasmid, the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1), ROR gamma transcriptional activity, and Hepatitis C Virus (HCV). | | Uses | CID 7309015 is an inhibitor of retinoic acid-related orphan receptor gamma (ROR-γ). CID 7309015 can be used for research of inflammation, NF-κB signaling or inflammatory arthritis[1]. | | IC 50 | ROR-γ | | References | [1] Li G, et al; Rheumatoid Arthritis Consortium International (RACI); Gupta N, Clemons PA, Stahl E, Tolliday N, Plenge RM. Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway. PLoS Genet. 2013 May;9(5):e1003487. DOI:10.1371/journal.pgen.1003487 |
| | 8-[3-(3,4-dimethoxyphenyl)acryloyl]-7-hydroxy-4-methyl-2H-chromen-2-one Preparation Products And Raw materials |
|